- Report
- April 2025
- 163 Pages
United States
From €2256EUR$2,500USD£1,955GBP
- Report
- May 2025
- 86 Pages
United States
From €3159EUR$3,500USD£2,737GBP
- Report
- September 2025
- 85 Pages
United States
From €3159EUR$3,500USD£2,737GBP
- Report
- July 2025
- 82 Pages
United States
From €3159EUR$3,500USD£2,737GBP
- Report
- May 2025
- 81 Pages
United States
From €3159EUR$3,500USD£2,737GBP
- Drug Pipelines
- April 2025
- 60 Pages
Europe
From €1805EUR$2,000USD£1,564GBP
- Clinical Trials
- April 2025
- 60 Pages
Africa
From €1805EUR$2,000USD£1,564GBP
- Clinical Trials
- April 2025
- 65 Pages
Middle East
From €1354EUR$1,500USD£1,173GBP
- Report
- April 2025
- 81 Pages
United States
From €3159EUR$3,500USD£2,737GBP
- Report
- July 2025
- 350 Pages
North America
From €3492EUR$3,869USD£3,025GBP
- Report
- July 2025
- 250 Pages
North America
From €3492EUR$3,869USD£3,025GBP
- Report
- July 2025
- 122 Pages
United States
From €3248EUR$3,599USD£2,814GBP
- Report
- June 2025
- 250 Pages
United States
From €2517EUR$2,789USD£2,181GBP
- Report
- June 2025
- 250 Pages
United States
From €2517EUR$2,789USD£2,181GBP
- Report
- June 2025
- 300 Pages
North America
From €3492EUR$3,869USD£3,025GBP
- Report
- June 2025
- 250 Pages
United States
From €2517EUR$2,789USD£2,181GBP
- Report
- June 2025
- 250 Pages
United States
From €2517EUR$2,789USD£2,181GBP
- Report
- June 2025
- 300 Pages
Europe
From €3492EUR$3,869USD£3,025GBP
- Report
- August 2025
- 122 Pages
North America
From €3609EUR$3,999USD£3,127GBP
- Report
- August 2025
- 122 Pages
North America
From €3609EUR$3,999USD£3,127GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more